Mimosa 5: Side Effects & Dosing

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Concise Prescribing Info

Contents

Mosapride citrate

Indications/Uses

GI symptoms associated w/ functional dyspepsia (chronic gastritis, heartburn, nausea, vomiting).

Click to view Mimosa 5 detailed prescribing information

Dosage/Direction for Use

Adult 15 mg in 3 divided doses.

Click to view Mimosa 5 detailed prescribing information

Overdosage

View Mimosa 5 overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

History of hypersensitivity to mosapride citrate or any other 5-HT₄ receptor agonists.

Click to view Mimosa 5 detailed prescribing information

Special Precautions

Not to be continued if no improvement in GI symptoms after approx 2 wk of therapy. Discontinue immediately if early signs/symptoms of hepatic toxicity or elevated liver enzymes occur. Situations where stimulated GI motility may be dangerous, including mechanical GI obstruction, perforation, or hemorrhage. Contraindicated w/ some prokinetic agents eg, cisapride, domperidone, levosulpride, metoclopramide. Severe (including fatal) hepatotoxicity. Avoid use during pregnancy & lactation. Discontinue breastfeeding during treatment. Childn. Elderly (reduced kidney & liver function).

Click to view Mimosa 5 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Mimosa 5 detailed prescribing information

Adverse Reactions

Diarrhoea/loose stools, dry mouth, malaise, headache, abdominal pain. Eosinophilia, elevated triglycerides, AST, ALT & γ-glutamyl transpeptidase levels.

Click to view Mimosa 5 detailed prescribing information

Drug Interactions

Decreased effect w/ anticholinergic agents (atropine sulfate & butyl-scopolamine Br). Increased max blood conc & AUC_0-4, & prolonged t_½ w/ erythromycin.

Click to view Mimosa 5 detailed prescribing information

Storage

View Mimosa 5 storage conditions for details to ensure optimal shelf-life.

Description

View Mimosa 5 description for details of the chemical structure and excipients (inactive components).

Action

View Mimosa 5 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

GIT Regulators, Antiflatulents & Anti-Inflammatories

ATC Classification

A03FA09 - mosapride ; Belongs to the class of propulsives. Used in the treatment of functional gastrointestinal disorders.

Thai FDA Category

Presentation/Packing

Form

Mimosa 5 FC tab 5 mg

Packing/Price

3 × 10's

Mimosa 5

mosapride

Manufacturer:

Unison

Distributor:

Medline

Marketer:

B.Grimm Pharma